Investment Pitches

Pitch Summary:
@investingluc argues a bullish case for Netflix ($NFLX), interpreting the company’s broad strategic experimentation as a strength rather than a weakness. The author highlights Netflix’s diversification beyond traditional movies/TV into live events, gaming, ad networks, and licensed content aggregation, enabled by global distribution and attention scale. These initiatives are framed not as a pivot but as additive revenue levers that monetize existing audience engagement. The pitch claims that this strategy differentiates Netflix from peers and justifies confidence at current prices (~$80.75). While the author cites personal conviction and market positioning, they do not provide a quantitative price target or detailed risk discussion.

BSD Analysis:
Netflix occupies a unique position in streaming with global reach and a strong base of subscribers, giving it optionality to test new revenue streams like live events, gaming, and advertising. Diversification makes strategic sense if execution supports monetization and retention without eroding core content value. However, execution risk remains high: live events and gaming require different capabilities, and integrating licensed content from deals like Warner Bros. introduces cost and complexity. Valuation support around $80.75 must be analyzed against subscriber growth trends, churn rates, and margin impact of diversified offerings. Competitive pressures from other streamers and shifts in advertising economics could compress returns. A disciplined view must balance the embedded franchise value against the risk of overextension and capital allocation implications.

Actual Post Content:
$NFLX is going through an identity crisis, but it's a good thing. Live events, gaming, original content, ad network, licensed content aggregator (via $WBD deal), and more... Most companies could NOT pull this off. But $NFLX can afford to do this because they already have the global distribution + attention. Concentration (movies/tv) to grow fast, diversification (everything above) to scale even bigger. $NFLX isn't pivoting...it's adding revenue levers. Trying to find new ways to monetize the attention they've already earned. Let things settle for a week, but I'm *very confident* that $NFLX is undervalued at $80.75 Attention rules the world, and Netflix owns it...at scale. they're doing something right if they have the ability to experiment. It's a really interesting time for the co, but I love it at these levels. I think we are close to max pain...

URL: https://x.com/investingluc/status/2013964720999391591

Pitch Summary:
@YellowLabLife highlights a strategic acquisition by Energy Fuels ($UUUU / EFR.TO) of Australian Strategic Materials (ASM) to build an integrated rare-earth mine-to-metal and alloy producer outside China. The post emphasizes the strategic importance of metallization technology and rare-earth supply chain control for industrial and defense applications. It is framed as a “master stroke”, tying REE metallization capacity with upstream production, and contrasting Western players with competitors. The author raises questions about sourcing strategies and recycling in the broader rare-earth value chain. The narrative is bullish on the acquisition’s potential to enhance Energy Fuels’ competitive position in magnets and critical materials, but gives no explicit valuation target.

BSD Analysis:
Energy Fuels is positioning itself as a vertically integrated rare-earth and critical materials supplier by combining its rare-earth oxide separation capability with ASM’s downstream metallurgy and alloy manufacturing. This move addresses a key bottleneck in Western supply chains and differentiates the stock from pure upstream producers. The strategic rationale is supported by U.S. policy interest in ex-China supply chain resilience and potential margin capture across multiple stages of processing. Execution risk includes integration of ASM operations, regulatory and shareholder approvals, and commodity price volatility. While acquisition news often boosts sentiment, fundamental investors should evaluate capital allocation, potential dilution, and the timeline for realizing downstream revenue. The expanded portfolio spanning uranium, REEs, and other critical minerals could improve long-term earnings power if downstream capacity reaches scale.

Actual Post Content:
Absolute master stroke by Energy Fuels $EFR.TO $UUUU here. The metallization technology ASM $ASM.AX controls at their South Korean facility is strategic and world class. LCM is in $USAR. ASM is in EFR. The two western metallization facilities are spoken for. And like the Koala mentioned earlier today, where is $MP on metallization? Where are all these companies on their upstream sourcing strategies? A metaphorical refinery isn’t worth much without an oil field. Mt Pass, Mt Weld don’t have big heavy REE compositions. Where are they on recycling? Will magnet producers get over metallization being done by a competing magnet producer (a q the LCM / USAR deal will answer in time)? The REE games continue… Energy Fuels to acquire Australian Strategic Materials to create new “mine-to-metal & alloy” rare-earth champion $EFR.TO $UUUU. Energy Fuels to acquire Australian Strategic Materials to create new “mine-to-metal & alloy” rare-earth champion. Mr. Mark Chalmers reports: DENVER, Jan. 20, 2026 /CNW/- Energy Fuels Inc. (NYSE: UUUU) (TSX: EFR), a leading U.S. producer of uranium, rare earth elements (REE), and other critical materials, today announced it has entered into a Scheme Implementation Deed (SID) to acquire 100% of the issued share capital of Australian Strategic Materials Limited (ASX: ASM) (ASM), a leading producer of REE metals and alloys. The transaction values ASM at US$299m and will be completed by way of a scheme of arrangement under Australian law. Strategic Rationale Energy Fuels is creating what the company believes will be the largest, fully integrated REE “mine-to-metal & alloy” producer outside of China to close a critical strategic gap in global supply chains for magnet applications, including automotive, robotic, energy, and defense technologies. Upon completion … Subject to satisfaction of all conditions, including shareholder and regulatory approvals, Energy Fuels expects that the transaction will close late in the first half of 2026. Energy Fuels is also developing heavy mineral sands projects … and is evaluating the potential recovery of certain medical isotopes from existing uranium process streams needed for emerging Targeted Alpha Therapy cancer treatments. … Forward-looking statements contained herein are made as of the date of this news release, and Energy Fuels disclaims any obligation to update any forward-looking statements.

URL: https://x.com/YellowLabLife/status/2013746198482391262

Pitch Summary:
@aleabitoreddit argues a bullish thesis on $VPG as a robotics supply play tied to Tesla’s Optimus ramp. The author initiated positions citing an alleged contract and high bill-of-materials contribution for each robot. They reference third-party commentary and believe the market has not priced in this exposure. Fundamentals such as revenue, gross margin, and net cash are noted as supporting durability, and vertical integration and proprietary material technology are highlighted. The thesis is framed as asymmetrical upside with robotics adoption inflecting. Key risks include the speculative nature of supply visibility and timing of robot production realization.

BSD Analysis:
VPG is positioned as a precision sensors and measurement technology company with exposure to multiple industrial end markets. Its valuation reflects a specialty niche within electronic components with modest scale compared to broader electronics peers. The tie-in to robotics demand — especially Tesla’s Optimus — is highly speculative until confirmed contract or revenue visibility appears in filings. Robotics and automation adoption would benefit demand for precision measurement technology, but execution risk is real: product adoption, timing of robot deployment, and confidentiality on OEM supply make revenue forecasts opaque. Fundamental analysis should focus on backlog, gross margin sustainability, and revenue diversification outside robotics. Macro trends favor automation, but converting that into predictable earnings for a small cap like VPG requires evidence beyond anecdote.

Actual Post Content:
I’ve initiated positions in $VPG ($573m). This is my actual/main robotics sector exposure going forward, tethered to $TSLA Optimus. Markets have completely overlooked this robotics sector play: For every Tesla Optimus deployed, $VPG likely takes an exceptionally high BOM for each. It’s a pretty open secret by now that VPG is likely a main supplier for Tesla Optimus Ramp. This was first discovered by Citron Research (not taking credit for this). In April 2025, Citron Research published a report calling VPG the “Hidden Tesla Optimus Play.” They pointed out that VPG announced a “major design win” with a humanoid developer in November 2023, right before Tesla revealed the Optimus Gen 2 in December 2023. Citron: “The evidence is conclusive: VPG is not only supplying Tesla Optimus but expects substantial revenues from this ramp-up, revenue currently invisible to the market due to confidentiality” ... this is speculation but ... incredible for $VPG given how small they are.

URL: https://x.com/aleabitoreddit/status/2013664829282599094

Pitch Summary:
@MarkosAAIG argues HBM looks “confusing” only when investors treat it as a single, binary supply constraint rather than a generational market tied to GPU platform transitions. He frames rumors of a Rubin delay and potential SK hynix guidance noise as a test case showing how headline-driven basket trades miss the real driver: mix and qualification timing across HBM3E to HBM4. NVIDIA’s roadmap is presented as the demand clock, with step-ups occurring at platform launches and value inflections occurring later, when high-density configurations stabilize and yields normalize. The key implication for NVIDIA is that short platform delays don’t destroy demand; they re-time the highest-value memory configurations and shift when suppliers monetize. He emphasizes that “HBM is tight” is not enough for alpha because suppliers monetize tightness unevenly based on qualification speed, packaging execution, and ability to ship premium SKUs at spec. Overall tone is bullish on the structural AI/HBM cycle while warning that near-term optics can compress without the long-term thesis breaking. The risk is misreading retiming as demand destruction and being positioned in the wrong tier of the platform wave.

BSD Analysis:
HBM is increasingly an architecture-dependent input, making NVIDIA’s platform cadence a de facto demand schedule for the entire memory stack. The economic variance across HBM generations is driven less by unit volume and more by configuration mix, yields, and qualification tier—areas that create large dispersion among suppliers. For NVIDIA, packaging and interconnect constraints (CoWoS and related bottlenecks) can shift timing and therefore shift when the ecosystem captures the highest-margin content, without changing secular AI compute demand. The market often overreacts to schedule rumors because it capitalizes near-term mix shifts as structural slowdowns. The more durable analytical edge is tracking the migration of high-density HBM4 content into volume and which suppliers can execute at spec under NVIDIA’s reliability requirements. Downside risk comes from deeper-than-expected platform delays or broader supply-chain limits that extend the high-value ramp materially. Upside risk is that once configurations stabilize, memory content per accelerator and pricing power reset higher, lifting the entire stack’s earnings power. The “winner” call within the basket is fundamentally an execution and qualification call, not a generic tightness call.

Actual Post Content:
HBM is only “Confusing” if you don’t understand the market $NVDA $MU $000660 SK hynix $005930 Samsung $AMD $TSN $Meta $MSFT $AVGO. Today there were some unconfirmed rumors about SK hynix potentially lowering guidance, and about NVIDIA delaying parts of the Rubin launch by a few weeks. We’ll come back to those points later in this article. The key thing to understand is that when you operate with enough depth in HBM and have the right reference points to benchmark developments against, noise becomes very easy to spot. Not because the news is irrelevant, but because you can immediately see where it sits in the system. That requires stopping to look at HBM as a single market, and starting to look at it as a sequence of platform-linked transitions. The core mistake: treathing HBM as a binary constraint Most investors still treat HBM as a binary condition. HBM is either tight, or it isn’t. And if it’s tight, you buy the whole basket Samsung, SK hynix, Micron. That works on the surface level, until it doesn’t. The problem is that HBM is not one market. It’s a layered, generational market whose economics are dictated by a few key factors: platform transitions, qualification depth, product mix, and timing relative to GPU roadmaps. Once you collapse all of that into a single statement “HBM is tight” you lose the ability to interpret anything that happens between those key points, and especially what happens between generations. And that’s exactly where most of the confusion comes from. The rumors we’re seeing today are a perfect confirmation of that. Today’s news is not the story it’s the testcase If you have the right understanding in place, you can very quickly backtrack developments to either noise or signal. Against that backdrop, we now have two pieces of noise today: chatter about a possible SK hynix guidance cut, and rumors of an NVIDIA Rubin delay tied to CoWoS packaging and interconnect issues. If you look at this at the surface, basket level, it can appear confusing or even contradictory. But that contradiction only exists if you’re using the wrong lens. Now that we’ve pointed out the news, we can move on to understanding it at the deeper level that actually matters. HBM demand is overweight mapped to Nvidia’s roadmap not the calendar HBM demand doesn’t scale linearly over time. It steps up with platform transitions. That fluctuation will always be present in this market. it’s just plain logic. The launch of Blackwell, the transition into Rubin, and eventually Rubin Ultra are not incremental events for a player like NVIDIA. They are major platform launches, and each of them represents a distinct economic regime for memory. That’s because every new platform introduces a new set of requirements, developed at the bleeding edge of innovation. Some of the key differences across these regimes are: different HBM densities, different stack heights, different qualification thresholds, different pricing power, and different packaging requirements. critical point in understanding this market is that the largest value inflection almost never happens at the start of a ramp. It happens one step later — when configurations stabilize, yields normalize, and the highest-density, highest-margin SKUs move into volume. That’s why the period between platforms is often the most misunderstood part of the entire cycle. Why product mix, not volume, drives outcomes We are currently in the HBM3E phase, and we’re transitioning toward HBM4 for the Rubin and Rubin Ultra platforms. Late-cycle HBM can continue shipping in meaningful volume that’s not the debate. To understand the gap between generations, and how different customer profiles affect outcomes, you have to understand what actually drives guidance, margins, and realized ASPs. And that is customer and product mix. Specifically, it comes down to: which generation, at what density, for which customer, and under which qualification tier. In this cycle, that distinction matters more than usual. HBM3E demand remains strong, but its role is shifting. That’s the crucial point. It’s becoming the bridge generation, not the destination. HBM4 is. Meanwhile, the real step-function in value sits with the next wave of platforms, where HBM content per unit jumps again and pricing power resets later in the product cycle. In between, that creates a temporary gap: demand visibility remains intact, structural tightness persists, but the highest-value configurations move slightly to the right. That exact gap is where you should place today’s NVIDIA and SK hynix rumors. It’s the zone where guidance optics can compress without the thesis breaking. And that’s why the chatter we’re seeing today fits the framework almost perfectly. Re-reading the SK hynix and NVIDIA noise correctly Building further on that framework, and looking at today’s developments through that lens, the chatter we’re seeing shouldn’t be surprising at a thesis level. A short platform delay driven by packaging or interconnect constraints does not destroy demand. Not at all. What it does is re-time product mix. Temporary spec normalization at the current generation level protects execution. But even small delays (like those referenced in the NVIDIA rumors) stretch the timeline for the highest-density configurations. And that point is absolutely key for memory suppliers. Near-term shipments can, and likely will, remain healthy. Backlogs stay full. But the revenue and earnings contribution tied to the next generation doesn’t fully show up yet. From the outside, if you don’t understand this dynamic, that can look like caution. From the inside, it’s simply sequencing and retiming. And that’s exactly why guidance noise can appear at the same time people believe the long-term outlook is the strongest creating unnecessary noise around a thesis that hasn’t actually changed. Why “HBM is tight” is not an investment thesis on its own In my opinion, this is where most market participants fall short. Buying the Samsung, SK hynix, and Micron basket can make sense if all you want is simple, structural exposure to the HBM market. But if you’re looking for alpha if you’re trying to identify which of the three is best positioned then “HBM is tight” is not a sufficient thesis. That narrative assumes that all tightness is monetized more or less equally. And that simply isn’t true. What actually decides outcomes during transition periods comes down to a different set of questions: who qualifies fastest at the next generation, who can ship volume at target specs, who captures premium pricing, and who is best positioned when the mix turns. Those are strategy questions. Samsung, SK hynix, and Micron each approach this market with a very different strategy and a very different positioning for the future. And to answer those strategy questions properly, you need to understand how NVIDIA’s roadmap and to a lesser extent other customers’ roadmaps feeds into memory demand, how ASIC adoption shifts the mix, and how qualification depth translates into market share and pricing. Not just whether supply happens to be constrained. What today actually confirms For me, today confirms something that matters far more than the headlines themselves. Most people still don’t understand how this market works beneath the surface. They see tightness and buy the basket. They see rumors and watch shares get dumped or bought purely on headlines. And when noise appears (like today) it immediately gets framed as a slowdown, triggering doubt and second thoughts. What this really shows is that HBM isn’t a headline market. It’s a transition market. And in transition markets, the difference between participation and outperformance is depth. You need a deeper understanding of how this market actually behaves, how specific dynamics influence outcomes, and which KPIs matter for each of the Big Three memory companies to execute on their individual strategies. This article is just a small snippet of my thinking, and of the information I’ve processed to build a framework that allows for a much deeper understanding of the HBM market. The full research is expected to launch in the coming weeks. It will be a 40-plus-page deep dive that provides the structure, context, and tools needed to understand how each player is positioned and what truly drives their execution strategy. This isn’t a finished argument it’s a snippet from much deeper HBM work. I’m already deep in the research, and part of the work is translating that complexity into something more accessible. That means sometimes focusing on structure and framing first, even if there’s no meat at the end yet. Agree N-1 won’t be stranded inference can absorb a lot. The key distinction is that utilization equals valuation. The rerating comes from where you sit in the platform wave and what margins that tier carries, not just from keeping fabs full. And ASICS still only be max 20% of AI chip market for the coming years. Nvidia will remain very dominant. Also Samsung is scaling hard and can adress that market also for example. And this is only a small snippet. In the research i’m building a whole framework you can test headlines against company strategy, abilities and productmix. It will give you a full basis to work with. I acknowledge the geopolitical tailwind for Micron but you still have to deliver. And Nvidia’s demands are cutting edge to assure tier 3 DC uptime. That’s the key narrative. Near-term demand is strong enough to lift all three, but not equally. If you want a pure basket approach, that’s a way to go. But the real differentiation shows up in how that demand is absorbed. I touched on that before. Execution on yields, packaging, and customer qualification will decide who turns demand into sustained earnings best in the coming years. That’s what I’m researching right now.

URL: https://x.com/MarkosAAIG/status/2013665843985399812

Pitch Summary:
@BlockChain187 argues the market is underestimating Intel’s 2026–2027 earnings power and frames the story as an impending EPS inflection rather than a simple momentum run. The pitch models 2026 EPS meaningfully above Street expectations by combining opex reductions from restructuring, gross-margin recovery as 18A production moves more silicon in-house, and incremental cash/EPS lift from expanded U.S. semiconductor tax credits. A further upside lever is a probabilistic Japan fund sale-leaseback that could monetize the Ohio fab, improve balance sheet optics, and increase capital flexibility. The author points to “institutional repositioning” signals and supply tightness in server CPUs as corroborating evidence. Risks center on execution: 18A yields, server demand/pricing, and the timing of any Japan transaction. The stance is explicitly bullish with high conviction and a 12-month base case target.

BSD Analysis:
Intel’s bull case hinges on two intertwined operating levers: manufacturing learning curves (18A yields and cost) and mix/price in server and client CPUs, both of which have nonlinear effects on gross margin. The market often discounts turnarounds because early signals arrive as one-time charges and messy transitional margins, while the payoff shows up later as normalized run-rate economics. If Intel truly internalizes the highest-value tiles at competitive yields, the “TSMC margin tax” compresses and Intel regains pricing flexibility versus AMD rather than competing as a structurally higher-cost designer. Policy support matters less as a headline and more as a cash-flow bridge that sustains capex through the ramp without forcing dilutive financing. The sale-leaseback angle is best viewed as balance-sheet optionality and capex smoothing, not pure spread arbitrage, because rent can offset interest savings. The key risk is that foundry execution disappoints and the company remains stuck with a hybrid model—outsourcing for performance, insourcing for fixed-cost burden—yielding no margin escape velocity. In that scenario, any multiple expansion would likely reverse quickly given the stock’s already improved sentiment.

Actual Post Content:
$INTC | Don't Call It A Comeback. This analysis presents a thesis that consensus significantly underestimates Intel's 2026-2027 earnings power. The Street expects $1.61 EPS in 2026. Our base case is $2.05, and our bull case reaches $2.35. The gap stems from four tailwinds the market has not fully priced: restructuring savings now flowing to the bottom line, margin expansion from internal 18A manufacturing, enhanced tax credits under the One Big Beautiful Bill, and a 40% probability of a Japan fund sale-leaseback that would unlock an additional $8-12 billion of capital. The thesis is not without risk. Execution uncertainty is real. But the evidence ladder is compelling, and the math checks. What follows is the complete case. The Setup. At 09:31 on January 14, 2026, Intel's stock gapped up 9% on volume that would eventually hit 147 million shares, triple its 90-day average. To put that in context: 147 million shares is roughly $7 billion changing hands in a single session. That is not retail enthusiasm. That is institutional repositioning. The catalyst was a single line buried on page four of a KeyBanc research note: "Intel is nearly sold out of server CPUs for 2026." That same morning, in New Albany, Ohio, Bechtel posted seven new job listings for Intel's delayed $28 billion fab complex. And somewhere in Cupertino, Apple's silicon team was running final simulations on Intel's 18A-P process design kit. Three data points. Three different geographies. One story. The Question. The question facing Intel investors is not whether the company can design competitive chips. Panther Lake, launched at CES three weeks ago, matches Apple's M4 in mobile benchmarks. That question is answered. The question is whether four separate tailwinds converge to create an EPS inflection that the market has not priced: the restructuring benefits that are just beginning to flow, the margin recovery from internal manufacturing, the enhanced tax credits signed into law last July, and the potential for a Japan fund transaction that would transform the Ohio fab from a liability into a source of capital. I think the answer is yes. But I could be wrong about the timing. What follows is the math, checked twice, and the specific conditions that would prove me wrong. Tailwind #1: Restructuring Accretion. Lip-Bu Tan inherited a company that had forgotten how to be lean. When he took the CEO role in March 2025, Intel employed 109,000 people. By year-end, that number will be approximately 75,000. In less than two years under combined leadership, Intel has reduced headcount by 35,500 positions. The restructuring charges were front-loaded by design. Q2 2025 alone carried $1.9 billion in one-time costs, impacting GAAP EPS by negative $0.45 per share in a single quarter. That number scared the market. But here is what the market missed: those costs are non-recurring, while the savings are permanent. The math is straightforward. Intel's average fully-loaded employee cost, including salary, benefits, equity compensation, and overhead, runs approximately $150,000 per year. A reduction of 35,500 employees translates to potential annual savings of $5.3 billion. Not all of that flows to the bottom line because Intel continues hiring in strategic areas. But CFO David Zinsner has guided operating expenses from $18.5 billion in 2024 to $17 billion in 2025 and $16 billion in 2026. That is $2.5 billion in run-rate savings. At a 21% effective tax rate and 5 billion diluted shares, $2.5 billion in operating expense reduction creates approximately $0.40 of EPS accretion. The market sees the GAAP losses from restructuring charges. It has not yet priced the normalized earnings power that emerges when those charges stop and the savings compound. Tailwind #2: Enhanced Tax Credits (OBBB). On July 4, 2025, President Trump signed the One Big Beautiful Bill Act. Buried in the 870-page legislation was a provision that increases the semiconductor manufacturing investment tax credit from 25% to 35% for facilities placed in service after December 31, 2025. Intel is the largest beneficiary. The company has guided 2025 gross capital expenditure of approximately $18 billion, with plans to deploy more than $27 billion of CapEx in 2025 versus $17 billion in 2024. The Arizona fabs, the Oregon facilities, and eventually Ohio all qualify for the enhanced credit. The math: a 10 percentage point increase on $20 billion of qualifying capex creates $2 billion of incremental tax benefit. The structure of the credit matters. It is refundable, meaning Intel receives cash even in years when it has no tax liability. This is not a deferred benefit that requires future profits to unlock. This is cash flowing into the balance sheet starting in 2026. At 5 billion diluted shares, $2 billion of tax credit benefit equates to $0.40 per share. But the timing is lumpy. Some of that benefit was already in the 25% baseline. The incremental 10 points, applied to qualifying expenditure, adds roughly $0.15 to $0.20 of annual EPS accretion depending on the timing of equipment placement. The enhanced credit also changes the economics of the Ohio project. At 35%, the federal government effectively covers more than one-third of Intel's qualifying investment. That shifts the risk-reward calculation for additional capacity buildout. Tailwind #3: Margin Expansion. To understand why margins matter, think of Intel as a restaurant that stopped cooking and started ordering from DoorDash. Lunar Lake and Arrow Lake are manufactured almost entirely by TSMC. Intel pays TSMC's fabrication costs plus TSMC's margin. The numbers tell the story plainly. TSMC charges roughly $20,000 to $30,000 per wafer at the 3-nanometer node. TSMC's gross margin is 58%. Goldman Sachs estimated Intel spent $5.6 billion on TSMC fabrication in 2024. The estimate for 2025 is $9.7 billion. Panther Lake changes this equation. The compute tile is manufactured internally on Intel 18A. The GPU tile still uses TSMC N3E. The I/O tile uses TSMC N6. CFO Zinsner has guided to appropriate margins by end of 2026 and industry acceptable by 2027. The leverage is brutal in its simplicity. Intel's annual revenue is roughly $54 billion. At that scale, five points of gross margin improvement creates $2.7 billion of incremental gross profit. Tailwind #4: Japan Fund Scenario (40% Probability). Intel broke ground on a $28 billion fab complex in New Albany, Ohio in 2022. It slipped to 2031. On September 4, 2025, Commerce Secretary Lutnick and Japan's Economy Minister Akazawa signed a memorandum of understanding that created a $550 billion strategic investment fund. Bechtel is already the contractor for Intel in the Ohio fab. Semiconductors are explicitly listed as a priority sector. Intel has already proven it can execute sale-leaseback transactions with Apollo in Ireland and Brookfield in Arizona. The Ohio fab fits the same template. A 49% sale could generate $8 to $12 billion in proceeds. If Intel receives $10 billion from a Japan fund sale-leaseback, debt reduction could save $500 million pre-tax, or approximately $0.08 per share after-tax. What is the probability? I estimate 35 to 45 percent within the next twelve months. My best guess is 40%. EPS Forecast: The Math. Starting point: Consensus expects $0.93 EPS for 2025 and $1.61 for 2026. Restructuring savings contribute approximately $0.40 per share. Margin expansion contributes approximately $0.35 per share. Tax credit benefit adds approximately $0.15 per share. Japan fund scenario contributes approximately $0.03 per share probability-weighted. Revenue growth contributes approximately $0.15 per share. 2026 base case EPS: $2.05. 2026 bull case EPS: $2.35. Risks and Countercase. Execution risks are real. Falsification Triggers include 18A yields, server revenue, gross margin, and Japan fund timing. Direction: BULLISH. Conviction: HIGH. 12-month base case target: $62. Bull case: $78. Let’s go! Ty. I was very conservative in this part of my analysis. This has so much upside but wanted to be very conservative. For specialized fab assets like these, cap rates are running in the 6 to 7% range based on current industrial net lease comps. Your math instinct is correct though. The rent burden isn’t nothing. The real value proposition isn’t just spread arbitrage. It’s about moving specialized assets off balance sheet, freeing up capex flexibility, and getting liquidity without touching operating capacity. Net-net, it probably ends up modestly accretive after rent burden, but the bigger win is balance sheet optics and capital flexibility at a moment when they desperately need both. Ty. Ty for the kind words. Hope it becomes true! Under promise, over deliver. It’s just the beginning. If anyone missed out on $MU … $INTC is even more compelling. Ty. Let’s go! You are now boarding S.S. Intel-ionaire. Let’s go and thanks! The vibes becoming reality. yessirrr

URL: https://x.com/BlockChain187/status/2013804235583037786

Pitch Summary:
@boring_invest lays out a detailed 2026 execution roadmap for ImmunityBio, framing the company’s transition from clinical uncertainty to commercial oncology scale. The bull case centers on ANKTIVA’s expansion across bladder and lung cancer indications, with regulatory milestones spread throughout the year. Movement into first-line bladder cancer is highlighted as a step-change catalyst that could dramatically expand the addressable market. European launches and late-stage lung cancer trials introduce global commercial optionality. Beyond clinical data, the author emphasizes ImmunityBio’s vertically integrated, AI-enabled NK cell manufacturing platform as a long-term cost and scalability moat. The thesis is explicitly bullish, positioning 2026 as the inflection year despite expected volatility.

BSD Analysis:
ImmunityBio is evolving from a single-asset biotech into a vertically integrated immuno-oncology platform with commercial and manufacturing leverage. The oncology landscape increasingly rewards therapies that extend survival while reducing chemotherapy toxicity, aligning with the NK cell paradigm. Regulatory success in earlier-stage indications materially de-risks downstream expansion by validating safety, manufacturing, and reimbursement pathways. The AI-enabled NK cell production strategy addresses one of cell therapy’s largest structural constraints: cost and scalability. Competitive risk remains high given entrenched checkpoint inhibitors and CAR-T incumbents, but differentiation lies in off-the-shelf NK economics. Valuation sensitivity will remain acute until revenue durability is proven across multiple geographies.

Actual Post Content:
The 2026 $IBRX Roadmap From Clinical What If to Commercial Powerhouse. Using the latest data available I’ve mapped out the must watch catalysts for $IBRX in 2026. To ensure this roadmap is as accurate and well organized as possible I partnered with my AI research buddy Gemini to synthesize the clinical timelines and regulatory filings. The 2026 Catalyst Calendar. Q1 The Regulatory De Risking. $IBRX has put pressure on the US FDA by seeking a fast track through Saudi Arabia. There are signs of the FDA waking up. ImmunityBio is set to submit additional data to the FDA by late February. A potential approval would expand their bladder cancer market significantly. Global revenue watch the first sales figures from Saudi Arabia where ANKTIVA is now approved for both bladder and lung cancer. Q2 The First Line Milestone. QUILT 2.005 enrollment for BCG Naïve first line bladder cancer is expected to complete by mid year. If ANKTIVA moves to first line the addressable patient population multiples. Q3 The Holy Grail Data and European Market Entry. EU commercial launch following conditional approvals with first sales expected. Lung cancer focus shifts to the Phase 3 ResQ201A confirmatory trial comparing ANKTIVA plus Tislelizumab versus Docetaxel. Early ANKTIVA data showed median overall survival of 21.1 months in responders versus historical chemotherapy survival of 7 to 9 months. Q4 The BLA Grand Slam. Expect the BCG Naïve BLA submission and updates on CAR NK lymphoma programs. Behind the scenes ImmunityBio is building an AI driven manufacturing moat including the world’s first AI driven robot to manufacture Natural Killer cells at scale. This creates a biological loop feeding global clinical outcomes back into manufacturing to optimize potency and reduce cost. The macro trend is the shift away from chemo only treatment toward NK cell immunotherapy. With median analyst targets north of $10.00 and preliminary 2025 revenue of $113M $IBRX is entering its execution era. Volatility will be high but the roadmap is clearer than ever. Disclaimer not financial advice. I hold a long term position in $IBRX.

URL: https://x.com/boring_invest/status/2013951604769407167

Pitch Summary:
@LiebermanAustin examines Ondas Holdings after its massive 2025 rally, questioning whether the stock represents a meme-driven surge or a structurally durable defense technology platform. The thesis frames Ondas as a Baby Prime positioned at the convergence of autonomous defense systems and regulated industrial connectivity. The company’s rail communications business provides a sticky, regulated base with long upgrade cycles, while its autonomous systems division targets fast-growing counter-UAS and security markets. Strategic acquisitions have expanded Ondas into a full-stack defense solution, but integration and geopolitical complexity remain meaningful risks. The author highlights that current valuation implies near-perfect execution across all segments. The stance is analytical rather than promotional, positioning the stock as high-potential but valuation-sensitive.

BSD Analysis:
Ondas represents an emerging defense-technology roll-up combining regulated industrial communications with autonomous security platforms. The rail communications segment benefits from regulatory capture and long asset lives, supporting recurring revenue and high switching costs. Autonomous defense systems address a rapidly expanding market shaped by drone warfare and critical-infrastructure security, but remain competitive and execution-intensive. The company’s capital-rich balance sheet enables inorganic expansion but raises integration, cultural, and return-on-capital risks. Valuation hinges on the conversion of backlog into scalable revenue and the ability to unify disparate technologies into a cohesive platform. Failure in any leg of the model could drive multiple compression, while success could position Ondas as a next-generation mid-tier defense contractor.

Actual Post Content:
Ondas Inc ONDS. Up 550 percent in 2025. Meme Stock or Is it the Real Deal. The defense and industrial sectors are currently undergoing a structural transformation from manned heavy assets to connected autonomous and swarming systems. Ondas Inc has positioned itself at the intersection of these two secular trends. Once viewed as a niche provider of radios for freight trains, Ondas has evolved into a diversified holding company attempting to provide autonomous drones to meet civilian and military security needs. The thesis rests on a three legged stool business model. First is Ondas Networks, a monopoly like utility providing the federally mandated IEEE 802.16t wireless standard for North American rail, generating high margin recurring revenue as 70,000 rail assets upgrade. Second is Ondas Autonomous Systems, a hyper growth defense technology division offering a full stack system of systems for aerial security through acquisitions including Airobotics, Iron Drone, Sentrycs and Roboteam, competing with players like Anduril amid global demand for counter UAS technology. Third is Ondas Capital, which uses a massive cash balance of nearly 1.5 billion dollars raised during defense tech optimism to consolidate the industry by acquiring revenue and technology. However the market is pricing this transition with extreme optimism. At a share price of 13.83 and market cap near 5.5 billion as of the pre market price this morning, Ondas trades at roughly 31 times projected 2026 revenue of 180 million. This valuation assumes flawless execution across rail upgrades, defense backlog conversion, and complex multinational integration. My goal is to determine whether Ondas is the next great compounder or a capital rich roll up facing multiple compression. I will dive into the technical nuances of their radio spectrum segment, the operational reality of drone in a box networks, geopolitical risks, and potential bear base and bull scenarios including the possibility of a ten times outcome.

URL: https://x.com/LiebermanAustin/status/2013946102945317216

Pitch Summary:
@SpecSitsCapMgmt flags CK Hutchison as a special situations setup where the holding company discount could compress if asset values are realized through transactions. The core argument is that the market price implies a steep discount to underlying businesses, while reported discussions around sales and listings suggest higher implied valuations. Potential catalysts include progress on a major ports transaction that carries political sensitivity, a possible IPO of the AS Watson retail arm, and a reported listing of the global telecom assets after the UK business combination with Vodafone. The author frames these as multiple independent “shots on goal” that could narrow the discount even if not all occur. They do not provide a formal price target, but imply meaningful upside via discount-to-NAV rerating rather than operational turnaround. Risks are implicitly tied to deal uncertainty, politics, and shifting circumstances, as the author notes outcomes can change. Overall stance is bullish on the setup as “worth the look.”

BSD Analysis:
CK Hutchison is best analyzed as a conglomerate discount play where value realization depends on corporate actions more than near-term operating momentum. The underlying portfolio spans ports, retail, telecom, and infrastructure-like assets, which typically attract different buyer bases and valuation frameworks, making sum-of-the-parts gaps common but persistent. A credible path to narrowing the discount requires either monetizations at transparent marks, structural simplification, or capital return that raises confidence in NAV conversion. Political and regulatory risk is especially acute when strategic infrastructure (e.g., ports) intersects with geopolitics, which can delay timelines and reduce certainty of proceeds. Telecom separation and retail IPO optionality can help crystallize valuation, but execution risk and market windows matter. The key diligence question is not whether NAV exists, but how management allocates proceeds (delevering vs buybacks vs dividends) and whether repeatable steps follow one-off events. In successful cases, rerating can be sharp; in unsuccessful cases, discounts can persist for years due to complexity and headline risk.

Actual Post Content:
Interesting things happening at CK Hutchison $1.HK $CKHUY. The company is a holdco that trades at 50% discount to NAV, but is said to be discussing sales and spinoffs at valuations that are much higher than the market pencils in. There are moves in different fronts, which could drive the discount lower: the company is still in discussions over its highly politicized $22 bi ports sale (which includes its 2 Panama ports); there are recent rumors around a $30 billion ipo of AS Watson, its retail arm; and Reuters has reported on a $20 bi listing of its global telco arm, following the recent merger of its UK business with Vodafone (there is a put/call that allows or forces CKH to sell its stake after 3 yrs). For reference, the current CK Hutchison Mcap is around $30 bi. Worth the look. Thank you! No specifics, but debt reduction, dividends and stock buybacks are possibilities. Things change…

URL: https://x.com/SpecSitsCapMgmt/status/2013930612361511246

Pitch Summary:
@crux_capital_ presents Precision Optics as a deeply overlooked micro-cap undergoing a structural transformation into a high-volume manufacturer with growing aerospace and defense relevance. The bull thesis centers on the company’s ability to solve size, weight, and power constraints for mission-critical optical systems, including recent U.S. Air Force augmented reality contracts. Aerospace revenue is inflecting sharply, supported by a growing backlog and capacity expansion, while legacy Tier-1 defense relationships create credibility and follow-on opportunities. A second growth engine comes from medical optics tied to robotic surgery platforms, where design-in dynamics create high switching costs and recurring revenue. Management guidance points to a 2026 financial inflection with revenue exceeding $25M and a move toward positive adjusted EBITDA. The stock is viewed as mispriced relative to peers due to ongoing margin pressure and micro-cap skepticism, despite improving fundamentals. Key risks include manufacturing yield stabilization, customer concentration, liquidity constraints, and dilution risk.

BSD Analysis:
Precision Optics sits at the intersection of defense-grade optical engineering and medical device manufacturing, two end markets that reward precision, reliability, and long qualification cycles. Industry structure favors incumbents with embedded designs and regulatory or security credentials, creating meaningful barriers to entry once programs scale. The company’s pivot from low-volume engineering to higher-throughput manufacturing introduces execution risk but also unlocks operating leverage if yields normalize. Aerospace and defense demand benefits from SWaP-C optimization trends across drones, AR training, and space-based systems, while medical optics provides a stabilizing counterbalance through recurring production runs. Competitive differentiation rests on ultra-miniaturization capabilities and vertical integration under ITAR compliance. Balance sheet tightness and customer concentration remain the principal risks until profitability is firmly established. A successful transition to positive EBITDA could justify valuation convergence with higher-multiple peers.

Actual Post Content:
A hidden gem in Aerospace and Defense. I was very pleased to stumble upon this company. I believe it is extremely overlooked and once the market catches up, we will see a re-rate. Disclaimer before we get started None of this is financial advice. I am not an investment advisor. I own shares. Do your own research. What is $POCI It’s not a pure-play A and D, but they have significant exposure and will be expanding further through 2026. I believe that this segment of their business is under-appreciated and therefore undiscovered and undervalued by the broader market. The company is currently undergoing a massive structural pivot from a high-mix, low-volume engineering shop into a high-volume manufacturing powerhouse for some of the biggest names in the world. POCI’s A and D exposure lies in its unique ability to solve the physics bottleneck of size and weight for mission-critical hardware. They recently landed a major contract to develop optical sub-assemblies for a U.S. Air Force augmented reality system designed for in-air combat training. Beyond AR, their aerospace business has hit a massive inflection point, delivering a record $2.5 million in revenue last quarter, an 800 percent surge compared to last year. They are currently sitting on a $9 million plus backlog in this business line and are aggressively expanding their production lines by another 50 percent. They’ve also won high-stakes work for jet engine inspection borescopes that must survive extreme temperatures. $POCI has spent decades building a Tier-1 reputation on programs like Night Vision systems, Fire Control, and Targeting and received the Small Business Subcontractor of the Year award. They are leveraging this legacy into satellite communications, precision aiming, and SWaP-C optimization. Management highlights their ability to align optics smaller than a grain of salt as critical for drones and man-portable tech. The market is underappreciating their positioning as a U.S.-based ITAR-registered manufacturer amid defense supply chain onshoring. Their medical business provides a second growth engine through robotic surgery optics with high switching costs and recurring revenue. The story for 2026 is the financial inflection point with over $25M in revenue guidance, a record backlog near $18M, a headquarters move to a 72,500 square foot facility, and a target of positive adjusted EBITDA. The market is pricing $POCI at roughly 1.6x sales versus peers above 2.0x, creating meaningful upside if execution continues. Risks include manufacturing yields, customer concentration, limited liquidity, and volatility. I will be covering this company more extensively going forward. Yes I am looking forward to that earnings to build my position if things are looking good. Hoping for a narrowing of that EBITDA loss as we move toward the goal of positive adjusted EBITDA for FY26. Oh yeah its crazy low. It took me a while to build my position. I like the story for sure. Let’s see how the A and D portion grows.

URL: https://x.com/crux_capital_/status/2013986348383060205

Pitch Summary:
@SJCapitalInvest argues that SkyWater Technology is undergoing a structural re-rating as markets shift from viewing it as a micro-cap foundry to a strategically critical defense and semiconductor manufacturer. The bull case centers on domestic supply chain security, DMEA Category 1A accreditation, and rising demand for U.S.-based trusted foundries amid geopolitical fragmentation. The author highlights strong technical momentum, noting a breakout above long-standing accumulation zones and limited historical resistance above $35. Fundamental catalysts include accelerating quantum manufacturing revenue, recently achieved profitability, and expectations for substantial Q4 revenue growth ahead of 2026 guidance. SkyWater’s acquisition of Infineon’s Fab 25 provides scale, volume stability, and revenue visibility, complementing its higher-margin quantum and defense work. Risks include potential equity dilution due to leverage and volatility near all-time highs, but the author remains bullish on continued upside driven by momentum and strategic scarcity.

BSD Analysis:
SkyWater occupies a rare position as a U.S.-owned semiconductor manufacturer with both classified defense accreditation and expanding commercial scale, placing it at the intersection of national security and advanced manufacturing. Industry structure favors trusted domestic capacity as geopolitical risk, export controls, and defense procurement increasingly prioritize secure supply chains over cost efficiency. The company’s hybrid model blends higher-margin, labor-intensive advanced technology services with lower-margin but scalable mature-node manufacturing, creating operating leverage as utilization rises. Fab 25 meaningfully shifts SkyWater’s revenue mix toward repeatable volume, reducing historical lumpiness while preserving upside from quantum and space programs. Competitive threats from larger foundries exist, but most lack the security credentials or flexibility required for classified and experimental workloads. Key risks include balance sheet strain, customer concentration in government contracts, and execution risk in scaling operations. If management delivers on medium-term revenue guidance, valuation support could increasingly resemble strategic foundry peers rather than defense assemblers.

Actual Post Content:
$SKYT Technical + Macro Analysis by Gemini 1/20/26 With the recent news and stock performance, I thought it was a good time for a proper Skyt Gemini update. I will admit I am pretty blown away by $SKYT's performance. I bought $SKYT on Dec 29th at $18.50. It just closed at $34.78 I have held off on buying more but its looking like its setting up for another run. Let's get into it. Remember, AI is not magic. This is trained on about 3 weeks of my conversations and document dumping intro Gemini. Unedited Gemini Text Below: $SKYT: The Sovereign Breakout. We are witnessing a structural repricing of SkyWater Technology. The market has stopped viewing it as a Micro-Cap Foundry and started pricing it as a Defense Prime amidst global supply chain fracturing. Here is how the Technicals and Macro represent a single, unified story. The Chart Entering Thin Air The Volume Shelf represents years of accumulation between $15 and $25 creating a concrete floor. Above $35 the volume profile disappears meaning little historical resistance. Near term Elliott Wave targets ~$46.85 and long term Cup and Handle points to $59–$60. The Macro Chaos Premium The No China No Taiwan trade, Section 232 tariffs, supply chain fracturing and DMEA Category 1A accreditation create a safe harbor for the Department of Defense. Investors are paying a Chaos Premium. The stock is trading at ~$34.78 near all time highs. Expect turbulence at $35. A daily close above $35.50 confirms breakout. Dilution risk exists with debt at ~$184M and a secondary offering is possible. Q4 earnings on February 25, 2026 are the next catalyst with consensus ~$160M revenue and ~112% YoY growth. The real trigger will be 2026 guidance. Verdict the easy money is done but momentum money remains. Stay long but keep powder dry. I bought $SKYT yesterday. Haven’t done enough research for a full thesis but top line this is a critical infra manufacturer in the quantum and semi space. Price is off here market is behind the revenue ramp. One portion of the business is cutting edge quantum manufacturing for the DOD D-Wave Silicon Quantum Computing and others partnered with Google margins 25 to 30 percent. Other business is semis not cutting edge but high volume from Infineon fab with lower margins. Market cap has not caught up. Flipped profitable last quarter. Trading at discount to semi manufacturing peers and quantum companies. One of the only American quantum foundries national interest in success here. More coming.

URL: https://x.com/SJCapitalInvest/status/2013783168919257558

Pitch Summary:
@VictorRenajlj makes a numbers-driven bull case for RIME, arguing the trucking and logistics market is massive but structurally inefficient due to fragmentation and poor utilization. He frames the core problem as empty miles and underfilled loads, which creates demand for software that can coordinate capacity in real time. He positions SemiCab as an AI logistics orchestration platform rather than a broker or load board, implying cleaner software economics and differentiation. The pitch emphasizes rapid growth, citing a sharp year-over-year revenue increase and rising ARR, plus a specific customer expansion example as incremental upside. He argues the stock is mispriced versus the growth profile because the market cap is tiny relative to the ARR run-rate he cites. Using ARR multiples, he derives a multi-step upside framework from mid-single-digit prices to the mid-teens, and potentially $30+ if ARR scales and the market re-rates the business. The key risks implied by the setup are whether the reported ARR trajectory is sustainable and whether RIME can convert logistics “TAM math” into durable enterprise adoption at scale.

BSD Analysis:
The durability of an “AI logistics orchestration” thesis hinges on product embedment: integrations into TMS/ELD workflows, measurable reduction in empty miles, and demonstrable ROI that survives cycles. Fragmentation is real, but selling into trucking can be noisy—retention and net revenue retention matter more than headline ARR growth in proving category leadership. Competitive risk is nuanced: incumbents (TMS vendors), brokers, and new AI-first entrants can all converge on “optimization,” so differentiation must be anchored in data access, network effects, and workflow stickiness rather than generic AI claims. If the platform is truly not a marketplace, it avoids some take-rate sensitivity, but it also must prove it can scale unit economics without intermediating freight. The valuation framework presented is multiple-based and assumes clean ARR quality; diligence should focus on ARR definition, contract duration, churn, and the mix of pilot vs enterprise-wide deployments. For micro-cap software, financing, liquidity, and reporting quality can dominate near-term price action regardless of fundamentals. Upside exists if RIME demonstrates repeatable enterprise expansions and standardized deployments across large shippers/carriers, but downside is meaningful if growth is lumpy, customer concentration is high, or “ARR” is overstated relative to cash receipts.

Actual Post Content:
Highly Bullish – Numbers-First Analysis (DYOR). The growth confirms it. Revenue hit +1,273.23% growth.. NASDAQ $RIME is operating inside a logistics system worth $11+ trillion globally, with $906B in U.S. trucking revenue, yet the industry still wastes capacity at scale. Roughly 16.7% of truck miles are empty, average load utilization is only ~57%, and 50%+ of truckloads move partially empty. With 91.5% of carriers running 10 trucks or fewer, fragmentation makes manual dispatch inefficient by design. This creates unavoidable demand for real-time orchestration software. RIME’s SemiCab is a pure-play AI logistics platform (not a broker, not a load board). The growth confirms it. Revenue hit $1.74M in Sep 2025, +1,273.23% YoY. ARR reportedly rose 220% from ~$2.5M to $8M+, with forward-looking ARR around $15M. A single enterprise expansion with Apollo Tyres can add up to $2.5M annually. Valuation is the anomaly. Shares trade near $0.86 with ~2.72M shares, implying ~$2.3M market cap. At 1× $15M ARR, implied price is ~$5.50–$6. At 3× ARR, ~$16–$17. If ARR scales to $25–$30M and the market assigns 3–4×, a $30+ share price is mathematically defensible. Massive TAM, accelerating revenue, minimal pure-play competition. Do your own research. For those who doubted ! Update 33% up !

URL: https://x.com/VictorRenajlj/status/2013761134860345851

Pitch Summary:
@daniel_koss initiates a high-risk, high-reward long in SCHMID Group, framing it as a misunderstood industrial enabler for next-gen AI compute packaging. He argues chip substrates are shifting from traditional organic boards to glass to handle warping and thermal issues as AI chips scale, and positions SCHMID as a uniquely capable supplier of wet-processing equipment needed to metallize microvias in glass core substrates. The core setup is a “valuation dislocation,” with the market discounting the stock as a distressed machinery name due to SPAC stigma and delayed audited filings. He believes the real business sits at the intersection of three demand cycles—AI scaling, commercial space growth, and Western reshoring—making SCHMID a chokepoint supplier rather than a generic capital goods company. The near-term catalyst is administrative and operational: clearing the audit overhang and converting an order backlog into recognized revenue, which he expects could re-rate the equity versus AI-adjacent peers. He explicitly lays out outcome ranges for 2026: a downside delisting scenario, a base case tied to audit clearance and revenue execution, and a bull case that adds large partnership confirmation and a short squeeze dynamic. Key risks are binary regulatory/filing outcomes, execution converting backlog, and the possibility the market never assigns SCHMID “AI infrastructure” multiples despite the narrative.

BSD Analysis:
This is fundamentally a “picks-and-shovels” bet on advanced packaging and substrate manufacturing capacity, where value accrues to constrained process steps (metallization, via formation, wet chemistry) rather than to the end chip designer. If glass core substrates transition from pilot to scaled deployment, the winners will be equipment vendors that sit behind qualification gates and can deliver repeatable yields at volume—especially in a market where packaging is increasingly the limiting factor. The key diligence item is whether SCHMID’s claimed differentiation is defensible (IP, process know-how, installed base, qualification lock-in) versus being a time-limited lead that attracts fast-follow competitors. The audit/filing overhang introduces idiosyncratic risk that can dominate fundamentals in the short run; sizing and time horizon matter more than typical industrial longs. Backlog conversion is not the same as earnings power—investors need to assess cancellation risk, customer concentration, gross margin profile, and working-capital intensity as deliveries ramp. The “short squeeze” element can amplify upside but is not an investment thesis on its own; the sustainable re-rate requires credible financial reporting, customer validation, and evidence that GCS capex is scaling. If the thesis is right, SCHMID’s multiple should migrate toward semiconductor equipment comparables, but the market will demand proof points on revenue quality and durability, not just technology narrative.

Actual Post Content:
Added a new stock today! SCHMID Group $SHMD. Looks like a great setup to me. High risk, very high reward. INTRO: Schmid Group is a 160-year-old German company that holds a potential monopoly on the "wet-processing" equipment needed for the next generation of AI computing: Glass Core Substrates (GCS). Modern AI chips are getting too big and hot for current plastic boards; they need glass to stop warping, and Schmid has the unique tech to plate the microscopic holes in that glass. THESIS: The investment thesis is based on a massive "valuation dislocation". Right now, the market is pricing $SHMD like a distressed, old-school machinery manufacturer because of a messy SPAC listing and delayed financial audits. However, the industrial reality is that Schmid rests at the convergence of three supercycles: AI scaling, the commercial space revolution, and Western supply chain reshoring. They are a critical choke point enabler for all three. The stock has a low float, high short interest, and trades at a massive discount to AI-adjacent peers like Camtek. The bet is that 2026 is the inflection point where the audit is finalized, their €95M order backlog converts to revenue, and the market realizes they hold the keys to solving the packaging "yield crisis" facing giants like NVIDIA and SpaceX. SCENARIOS (2026): Bear Case ($1–$3): They fail to file the delayed 20-F audit and get delisted to the OTC Pink Sheets, forcing immediate institutional dumping regardless of the underlying technology. Probability: 20% | Return: -80% Base Case ($15–$25): The KPMG audit clears, removing the "uninvestable" overhang. They execute on guidance to hit €100M+ revenue in 2026 as the industry shifts from plastic to glass substrates. Probability: 50% | Return: +150% Bull Case ($50–$80): Audit clears AND rumored partnerships with Broadcom or SpaceX for their massive Texas manufacturing expansion are confirmed publicly. This catalyst sparks a violent short squeeze on the tiny available float. Probability: 30% | Return: +700% DISCLAIMER: This is not financial advice. I am semi-retarded. This post is for entertainment only; don’t try this at home unless you enjoy the taste of instant ramen and sleeping in your car. Do your own DD.

URL: https://x.com/daniel_koss/status/2013681515461288269

Pitch Summary:
Republic Services, Inc. (RSG) – Addition reflects attractive opportunity to increase our exposure in a defensive and resilient business model. The waste management industry has lagged the broader market this year due to cyclical volume weakness in construction, demolition, and the industrial sector. Despite these short-term headwinds, RSG continues to exhibit operational strength through pricing power and cost controls, which have led to stronger margins. We remain attracted to the high-quality, essential business with strong and stable cash flow generation. Recently, insiders have bought shares in the open market, which we view as an additional data point to the attractive valuation.

BSD Analysis:
Republic Services monetizes trash, which is one of the most stable demand drivers imaginable. Waste volumes don’t swing wildly with GDP, and pricing resets annually through contracts. Route density and landfill ownership create brutal local monopolies. Investors underestimate how strong pricing power is when alternatives don’t exist. Environmental regulation actually strengthens incumbents by raising barriers to entry. Cash flow is predictable and capital-light relative to asset life. M&A is disciplined, not empire-building. This is infrastructure-level stability with inflation protection baked in.

Pitch Summary:
Norfolk Southern Corporation (NSC) – Added to our NSC position after the shares pulled back despite the pending UNP deal. It is currently trading at a discount to the value of the UNP deal and the rail industry is out of favor. While most recent earnings were softer than expected, NSC has shown signs of improving its execution and volumes should return incrementally. Lastly, the chairman stepped up and purchased shares in the open market, which we view as a sign of conviction in the business.

BSD Analysis:
Norfolk Southern is freight infrastructure that only looks cyclical until you realize how hard it is to replace rail capacity. East Coast rail density and terminal access create a moat trucks can’t replicate at scale. Operating ratio improvement is the real driver, not volume heroics. Investors fixate on labor, safety, and regulatory noise, which are real but manageable over time. Pricing power exists because rail remains the lowest-cost option for heavy freight. Capital intensity is high, but replacement cost is higher. This is industrial infrastructure where efficiency gains quietly compound. Rails don’t need growth narratives to earn returns.

Pitch Summary:
We elected to exit DV given it was a stub position and we had higher conviction elsewhere. Over time, the business demonstrated greater earnings variability and less visibility than anticipated, with results increasingly influenced by cyclical brand advertising budgets. At the same time, execution shortfalls reduced our confidence in management, and our assessment of ad verification evolved, particularly in a tighter spending environment, where it proved less mission-critical than initially expected.

BSD Analysis:
DoubleVerify monetizes trust in digital advertising, which becomes more valuable as fraud and opaque metrics proliferate. Verification is a tax on bad behavior, and bad behavior isn’t going away. Advertisers don’t cut verification first when budgets tighten — they cut waste. Switching costs are procedural, not emotional, but still sticky. Investors treat DV like adtech beta and miss its defensive characteristics. Expansion into connected TV extends the runway meaningfully. Margins reflect software economics, not media cycles. This is ad plumbing paid for by skepticism.

Pitch Summary:
CCC operates a vertically integrated, mission-critical software platform for the automotive insurance ecosystem. CCC commands a monopoly like position, handling over 80% of U.S. auto claims, and leverages scale, network effects, and high customer retention to maintain its competitive edge. This enables durable high-single-digit organic growth driven by product upsells and new customer wins in a fragmented repair market. The company is also benefiting from the digitalization of more complex auto claims. We believe the market is discounting a high-quality company amid short term concerns of slower growth from new product rollouts and AI risks. In reality, CCC’s AI-powered offerings have helped its core business by enhancing claims automation, accuracy, and speed. CCC implemented an accelerated share repurchase program and insiders have been buying shares in the open market to show conviction in the business. We believe the margin of safety is supported by the business’s stability and a management team with a strong track record of innovation.

BSD Analysis:
CCC owns the digital workflow backbone of auto insurance claims, a process no carrier wants to reinvent. Once integrated, switching systems risks operational chaos, which is the moat. Rising repair complexity and total-loss rates actually increase CCC’s relevance. Investors fixate on growth deceleration and miss durability. Data scale improves accuracy and pricing power over time. Subscription revenue smooths cycle volatility. AI enhances automation inside workflows customers already trust. This is insurance infrastructure, not discretionary software.

Pitch Summary:
GTES reacted negatively to the announced restructuring and footprint optimization actions, along with ERP implementation headwinds. These factors are expected to pressure margins in early 2026 and delay the EBITDA margin target to 2027. Despite near-term challenges, the underlying business is performing well amid weak industrial activity, and management remains disciplined in driving operational improvements. We believe GTES is well positioned for strong earnings growth, supported by secular tailwinds such as electrification and chain-to-belt retrofitting, and continued productivity gains.

BSD Analysis:
Gates makes belts, hoses, and power transmission components that factories, vehicles, and machines literally cannot run without. Products look commoditized until downtime costs dwarf price differences. Replacement demand anchors revenue even when OEM volumes slow. Scale, distribution, and engineering depth create real switching friction. Investors lump Gates into generic industrial cyclicality and miss the aftermarket math. Margin improvement comes from mix and pricing discipline, not heroic growth. Cash flow matters more than top-line excitement here. This is industrial infrastructure hiding in plain sight.

Pitch Summary:
CERT was a bottom performer as the stock sold off on softer top line and bookings results, despite improving profitability and higher EPS guidance. While organic software growth has fallen short of expectations, margins, cash flow, and software mix continue to trend positively. We continue to like CERT for its dominant market position, low capital intensity, strong cash flow generation, and a long-term growth opportunity as computer simulation adoption expands over traditional methods.

BSD Analysis:
Certara sells decision-critical software embedded deep in drug development workflows where mistakes are expensive and reputations are permanent. Regulators increasingly expect quantitative modeling, which turns Certara into infrastructure rather than optional tooling. Biotech funding cycles pressure growth optics, not customer dependence. Switching costs are intellectual and regulatory, not contractual, which is stronger than it looks on paper. Investors confuse slower bookings with competitive loss. Software margins expand as services become a smaller mix over time. Expansion comes from deeper penetration, not logo chasing. This is life sciences plumbing compounding behind the scenes.

Pitch Summary:
NEU was a weaker performer as a softer global environment (mostly China's slowdown) pressured Petroleum Additives volumes and margins. The Specialty Materials business had lumpy demand, which weighed on results. Lower oil prices reduced operating leverage. Despite near-term pressure, we continue to view NEU as a strong business with disciplined capital allocation, balance sheet flexibility, and strong cash flow generation.

BSD Analysis:
NewMarket operates in fuel and lubricant additives, a niche where chemistry, regulation, and OEM approvals create brutal barriers to entry. This is not a volume business — it’s a performance business where failure isn’t tolerated. Demand tracks miles driven and engine complexity, not GDP growth headlines. EV narratives distract from the reality that internal combustion will dominate globally for decades. Pricing power exists because customers care more about engine protection than pennies per gallon. Growth is slow, but margins are structurally high and stable. Investors overlook NewMarket because it’s boring and lightly covered. This is industrial specialization that quietly prints cash year after year.

Pitch Summary:
HAE entered the quarter with very low expectations, which helped drive a strong stock reaction following earnings. Guidance increased due to improving margins from initiatives. HAE will likely reach its long-term margin targets outlined at its prior investor day. While some parts of the business are still improving, strength in other areas has helped offset those challenges. Buybacks increased at these depressed valuation prices, enhancing shareholder value. Overall, we believe the setup remains attractive, supported by the company’s underlying quality.

BSD Analysis:
Haemonetics sells mission-critical blood management systems embedded in hospital workflows where switching risk is clinical, not financial. Demand is tied to procedures and transfusion needs, not elective consumer cycles. Once hospitals standardize on a platform, inertia is powerful. Investors worry about product cycles and reimbursement noise. Yet consumables and disposables drive recurring revenue. Innovation improves outcomes and efficiency rather than chasing novelty. Margins expand as scale and mix improve. This is healthcare infrastructure that quietly compounds.